• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clinical and laboratory characteristics of a new influenza A (HIN1) epidemic

tetano

Editor, Senior Moderator
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Apr;24(2):134-5.
[Clinical and laboratory characteristics of a new influenza A (HIN1) epidemic].

[Article in Chinese]

Feng YQ, Guo TS, Liu LM, Li YL, Li B, Liu ZG, Sun ZQ, Zhao M, Mao YL, Li BA.

Clinical Laboratory Center, 302 Hospital of PLA, Beijing, China.
Abstract

OBJECTIVE: To analysis the clinical and laboratory characteristics of Patients infected with new influenza A (HIN1) virus.

METHODS: All cases with new influenza A (H1N1) confirmed on polymerase chain reaction assay on throat swabs. There were included in a prospective evaluation of clinical characteristics, laboratory results, treatment and overcome of new influenza A (H1N1).

RESULTS: There were 35 patients in the epidemic. Clinical illness developed within a mean of 1.7 days. Fever occurred in 97.1%, sore throat 65.7% cough 51.4%, headache 28.6%, and myalgia 31.4%. All patients were treated with oseltamivir lasted 5 days. The mean duration of viral shedding was 4.5 days. All were cured and left hospital after day 7.

CONCLUSION: It was infected by new influenza A (H1N1) typically in this epidemic.

PMID: 21110436 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/21110436
 
Back
Top Bottom